Midazolam Intranasal Spray 5mg from Canada
Single-use intranasal spray delivering 5mg midazolam per dose for rapid seizure termination in outpatient settings. Packaged in metered-dose nasal applicators for prophylactic epilepsy management. Classified in HTS 3004.90.92.38 for transdermal-like administration systems containing midazolam salts as hypnotics/sedatives.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Validate nasal bioavailability studies for approval; ensure tamper-evident packaging
• Pitfall: misdeclaration as cosmetic spray leading to reclassification
• Track shelf-life rigorously post-import